Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07523503
Recruiting
Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in Post-Stroke Rehabilitation
Not applicable · Pakistan · 1 site
Registry update: 13 Apr 2026
NCT07527156
Recruiting
Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure
Phase 4 · Czechia · 1 site
Registry update: 14 Apr 2026
NCT06987045
Recruiting
Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study
Not applicable · United Kingdom · 1 site
Registry update: 4 Jun 2026
NCT07518290
Recruiting
Remotely Supervised Home-based Transcranial Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease
Not applicable · China · 1 site
Registry update: 22 Sept 2026
NCT07296315
Recruiting
Confirmatory Clinical Study in Active Ulcerative Colitis
Phase 2 · Czechia, Georgia, Italy, Moldova, Poland, Serbia, Ukraine, United States · 78 sites
Registry update: 21 Oct 2026
NCT07146802
Recruiting
Personalized Metacognitive Training for Psychosis: A Randomized Controlled Trial
Not applicable · France · 1 site
Registry update: 20 Aug 2026
NCT07430956
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Phase 3 · Bulgaria, Canada, Germany, Spain, Hungary, Italy, Latvia, Netherlands, Poland, Portugal, Romania, Sweden, United States · 139 sites
Registry update: 14 Oct 2026
NCT07299422
Recruiting
A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus
Phase 2 · China · 2 sites
Registry update: 29 Sept 2026
NCT07225270
Recruiting
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Phase 3 · Austria, Belgium, Czechia, Germany, Denmark, Spain, Finland, France, Hungary, Italy, Japan, Norway, Poland, United States · 119 sites
Registry update: 6 Oct 2026
NCT07308106
Recruiting
A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities
Phase 2 · China · 1 site
Registry update: 30 Jul 2026
NCT07405359
Recruiting
PVI Alone Versus PVI Plus PWI and SVCI With PFA
Not applicable · United States · 1 site
Registry update: 14 Jul 2026
NCT07298005
Recruiting
Sonlicromanol in Post-COVID
Phase 2 · Netherlands · 1 site
Registry update: 18 Aug 2026
NCT07464756
Recruiting
SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer
Phase 2 · China · 1 site
Registry update: 16 Jul 2026
NCT07318714
Recruiting
A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke
Phase 1/2 · Japan · 5 sites
Registry update: 9 Jul 2026
NCT07227584
Recruiting
ALL Backbone in AYAs
Phase 2 · United States · 1 site
Registry update: 17 Aug 2026
NCT07538947
Recruiting
Real-Time Imaging to Improve Lung Cancer Diagnosis : Comparing Confocal Laser Endomicroscopy (CLE) With Standard Biopsy for Quicker and Safer Detection of Non-Small Cell Lung Cancer
Not applicable · France · 1 site
Registry update: 20 Apr 2026
NCT07416474
Recruiting
RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)
Phase 3 · China · 77 sites
Registry update: 14 Jul 2026
NCT07543757
Recruiting
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Not applicable · United States · 7 sites
Registry update: 28 Sept 2026
NCT07485543
Recruiting
Safety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years
Early phase 1 · China · 1 site
Registry update: 1 Oct 2026
NCT07540221
Recruiting
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Phase 3 · Czechia, Poland, Romania, United States · 15 sites
Registry update: 9 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.